4

4.00 (0.82%)

As of Mar 06, 2024

Cellectar Biosciences, Inc. [CLRB]

Source: 

Company Overview

We are a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer. Our core objective is to leverage our proprietary phospholipid drug conjugate ™ (PDC™) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects.

CountryUS
Headquartersflorham parknew jersey
Phone Number(608) 441-8120
Industrypharmaceutical preparations
CEOJames V. Caruso
Websitewww.cellectar.com